Increased fatty acid delivery by tumor endothelium promotes metastatic outgrowth

JCI Insight. 2025 Apr 8;10(9):e187531. doi: 10.1172/jci.insight.187531. eCollection 2025 May 8.

Abstract

Metastatic outgrowth in distant microscopic niches requires sufficient nutrients, including fatty acids (FAs), to support tumor growth and to generate an immunosuppressive tumor microenvironment (TME). However, despite the important role of FAs in metastasis, the regulation of FA supply in metastatic niches has not been defined. In this report, we show that tumor endothelium actively promotes outgrowth and restricts antitumor cytolysis by transferring FAs into developing metastatic tumors. We describe a process of transendothelial FA delivery via endosomes that requires mTORC1 activity. Thus, endothelial cell-specific targeted deletion of Raptor (RptorECKO), a unique component of the mTORC1 complex, significantly reduced metastatic tumor burden that was associated with improved markers of T cell cytotoxicity. Low-dose everolimus that selectively inhibited endothelial mTORC1 improves immune checkpoint responses in metastatic disease models. This work reveals the importance of transendothelial nutrient delivery to the TME, highlighting a future target for therapeutic development.

Keywords: Cancer immunotherapy; Endothelial cells; Immunology; Metabolism; Oncology.

MeSH terms

  • Animals
  • Cell Line, Tumor
  • Endothelial Cells / metabolism
  • Everolimus / pharmacology
  • Fatty Acids* / metabolism
  • Female
  • Humans
  • Mechanistic Target of Rapamycin Complex 1 / antagonists & inhibitors
  • Mechanistic Target of Rapamycin Complex 1 / metabolism
  • Mice
  • Neoplasm Metastasis
  • Regulatory-Associated Protein of mTOR / genetics
  • Regulatory-Associated Protein of mTOR / metabolism
  • Tumor Microenvironment / immunology

Substances

  • Fatty Acids
  • Mechanistic Target of Rapamycin Complex 1
  • Regulatory-Associated Protein of mTOR
  • Everolimus